Precision Biosciences Inc., of Research Triangle Park, N.C., closed a $25.6 million series A financing led by Venbio. Fidelity Biosciences, Amgen Ventures, Baxter Ventures, Osage University Partners, the Longevity Fund and unnamed investors also participated in the oversubscribed financing.